id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-293522-gg706q8s	Toumi, Mondher	Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al	2020-05-13		.txt	text/plain	5234	277	51	title: Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al The results of a clinical trial comparing hydroxychloroquine with or without azithromycin to the standard of care for the treatment of COVID-19 were recently published by Philippe Gautret et al. This study provides outstanding results for the combination of hydroxychloroquine and azithromycin over the standard of care, but the evidence was deemed insufficiently robust to warrant a public health decision to widen the use of hydroxychloroquine for the treatment of COVID-19. The results of a clinical trial comparing hydroxychloroquine with or without azithromycin to the standard of care for the treatment of COVID-19 were published in the International Journal of Antimicrobial Agents by Philippe Gautret et al. The US Centers for Disease Control and Prevention provides information on the use of hydroxychloroquine and chloroquine in the USA to treat coronavirus 2infected patients.	./cache/cord-293522-gg706q8s.txt	./txt/cord-293522-gg706q8s.txt